Advancing Early Detection: Autoimmune Screening in Type 1 Diabetes
A panelist discusses how autoimmune screening through detection of diabetes-specific autoantibodies serves as a critical tool for identifying pre-symptomatic type 1 diabetes (T1D), enabling earlier intervention before significant beta cell loss occurs and potentially changing the disease trajectory through timely management strategies.
Video content above is prompted by the following:
- What role does autoimmune screening play in identifying and diagnosing patients with T1D earlier?
- In what patients do you recommend screening for autoantibodies?
- Do you think autoimmune screening initiatives will gain momentum in the next few years?
- How can health care systems and payers improve early screening and diagnosis to better preserve beta cell function?
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Recent Videos
Related Content
